Assignee
BIOFERMIN PHARMACEUTICAL CO LTD
JP·3 granted patents·2 pending applications·0 citations·filing 2017–2020
Top patents by PatentIndex Score
5 records- 0152US2022387526A1Uremic toxin reducing agentBIOFERMIN PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 0247US11224622B2Agent for preventing or treating fat-associated diseases and/or inflammationBIOFERMIN PHARMACEUTICAL CO LTD·Filed 2018·Granted Jan 18, 2022·0 cites·7 claims
- 0344US11376287B2Agent acting on transcellular ion transporter in intestinal tract, agent for activating chloride channel, agent for preventing or treating renal disease, or agent for promoting defecationBIOFERMIN PHARMACEUTICAL CO LTD·Filed 2017·Granted Jul 5, 2022·0 cites·11 claims
- 0441US11219650B2Agent for preventing or treating small intestinal injury induced by specific NSAID and PPIBIOFERMIN PHARMACEUTICAL CO LTD·Filed 2018·Granted Jan 11, 2022·0 cites·5 claims
- 0539US2020338144A1Agent for preventing or treating small intestinal injury induced by non-steroidal anti-inflammatory drug and proton pump inhibitorBIOFERMIN PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BIOFERMIN PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →